Pulse-dosing and conventional application of doxepin: Effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system

被引:30
作者
Deuschle, M [1 ]
Schmider, J [1 ]
Weber, B [1 ]
Standhardt, H [1 ]
Korner, A [1 ]
Lammers, CH [1 ]
Schweiger, U [1 ]
Hartmann, A [1 ]
Heuser, I [1 ]
机构
[1] MAX PLANCK INST PSYCHIAT, INST CLIN, D-80804 MUNICH, GERMANY
关键词
D O I
10.1097/00004714-199706000-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been shown that a single pulse-dosing (PD) dose of clomipramine improves depressive symptoms. However, so far PD and conventional (CONV) application of antidepressants have never been directly compared for an extended period. We performed a double-blind study of PD and CONV application of doxepin (DOX) in depressed patients. After a 1-week placebo treatment, nine patients in the PD group received 250 mg of DOX every 6 days and placebo on the other days until day 39. Ten patients in the CONV group received increasing dosages of DOX until day 7 and 250 mg DOX on the other days for 39 days. Three dexamethasone (DEX)-suppression/corticotropin-releasing hormone (CRH)-stimulation tests were completed: (1) during the initial placebo period; (2) on day 9; and (3) on day 21. In the PD group, scores on the Hamilton Rating Scale for Depression (HAM-D) differed from baseline only after day 36 (17.1 +/- 7.0 vs. 22.7 +/- 2.8, p < 0.03). In the CONV group, however, HAM-D scores improved significantly after 2 days (22.8 +/- 7.2 vs. 26.5 +/- 5.7, p < 0.02) and continued to improve until day 39 (7.3 +/- 5.8). From day 25 to 39, there were significant differences between the HAM-D scores of the two groups. In the PD group, the decline of cortisol after DEX pretreatment was nonsignificant (NS) at both follow-up test occasions (35.9 +/- 40.7 vs. 24.0 +/- 20.7 vs. 23.6 +/- 26.6 mu g/mL). In the CONV group, a significant decrease was observed at the second test (61.8 +/- 61.9 vs. 10.7 +/- 4.2 vs. 19.8 +/- 19 mu g/mL, p < 0.05, respectively, NS). The area under-the-curve cortisol response after CRH was attenuated in the PD group (5,667 +/- 2,910 vs. 1,883 +/- 2,178 vs. 2,239 +/- 2,583 [arbitrary unit], p < 0.01, respectively, p < 0.01) and in the CONV group (5,710 +/- 4,734 vs. 1,267 +/- 2,053 vs. 445 +/- 1,016 [arbitrary unit], NS, respectively, p < 0.02). We conclude that CONV application of DOX is clinically superior compared with PD and that both modes of application have attenuating effects on hypothalamus-pituitary-adrenal system activity.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 25 条